Facetten
Zugriff
Einrichtung
Medientyp
- Text 7
Karte
Erscheinungsjahr
Autor/in
- Moreau, Philippe
- Weisel, Katja
- San-Miguel, Jesus 3
- White, Darrell 3
- Anderson, Larry D 2
- alle zeigen
Sprache
- Englisch 7
7 Einträge gefunden
-
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: a subanalysis of OPTIMISMM by clinical characteristics
- Richardson, Paul G
- Schjesvold, Fredrik
- Weisel, Katja
- Moreau, Philippe
- Anderson, Larry D
- White, Darrell
- Rodriguez-Otero, Paula
-
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
- Dimopoulos, Meletios
- Weisel, Katja
- Moreau, Philippe
- Anderson, Larry D
- White, Darrell
- San-Miguel, Jesus
- Sonneveld, Pieter
-
Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR
- Weisel, Katja
- Mateos, Maria-Victoria
- Gay, Francesca
- Delforge, Michel
- Cook, Gordon
- Szabo, Zsolt
- Desgraz, Renaud
-
Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR
- Avet-Loiseau, Hervé
- San-Miguel, Jesus
- Casneuf, Tineke
- Iida, Shinsuke
- Lonial, Sagar
- Usmani, Saad Z
- Spencer, Andrew
-
Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis
- Dimopoulos, Meletios A
- Niesvizky, Ruben
- Weisel, Katja
- Siegel, David S
- Hajek, Roman
- Mateos, María-Victoria
- Cavo, Michele
-
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
- Weisel, Katja
- Dimopoulos, Meletios
- Moreau, Philippe
- Yagci, Munci
- Larocca, Alessandra
- Kanate, Abraham S
- Vural, Filiz
-